NSMCE2 and osteosarcoma: However, in contrast to TOP3A and NBS1, MMS21 amplification was also observed at high frequency in ALT‐negative tumors, suggesting that it does not have a specific role in the maintenance of ALT telomeres in pediatric osteosarcomas.